Dehydroeburicoic acid

CAS No. 6879-05-6

Dehydroeburicoic acid( —— )

Catalog No. M21680 CAS No. 6879-05-6

Dehydroeburicoic acid induces necrotic cell death that involves Ca(2+) overload mitochondrial dysfunction and calpain activation in human glioblastomas.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dehydroeburicoic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Dehydroeburicoic acid induces necrotic cell death that involves Ca(2+) overload mitochondrial dysfunction and calpain activation in human glioblastomas.
  • Description
    Dehydroeburicoic acid induces necrotic cell death that involves Ca(2+) overload mitochondrial dysfunction and calpain activation in human glioblastomas.
  • In Vitro
    Dehydrotrametenolic acid selectively inhibits the growth of H-ras transformed cells with a GI50 value of 40 μM.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    NOS
  • Recptor
    NO Synthase|TNF-α|NOS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6879-05-6
  • Formula Weight
    468.73
  • Molecular Formula
    C3lH48O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 1 mg/mL (2.13 mM)
  • SMILES
    CC(C)C(=C)CC[C@H]([C@H]1CC[C@@]2([C@@]1(CC=C3C2=CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dehydroeburicoic acid induces calcium- and calpain-dependent necrosis in human U87MG glioblastomas.Chem Res Toxicol. 2009 Nov;22(11):1817-26.
molnova catalog
related products
  • Camstatin

    An analog of PEP-19 with enhanced binding to and antagonism of calmodulin.

  • ASP 9853

    A potent, orally active iNOS inhibitor that prevents dimerization of iNOS.

  • AVE-9488

    AVE-9488 is a novel endothelial NO synthase (eNOS) enhancer that upregulates eNOS expression, induces NO production, and may ameliorate portal hypertension.